Clinical Trials
2 trialsNCT03702231 2023-08-04
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01254630 2019-09-30
V212-011
Merck Sharp & Dohme LLC
Phase 3 Completed